TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
126.79
-0.83 (-0.65%)
At close: Dec 12, 2025, 4:00 PM EST
128.40
+1.61 (1.27%)
Pre-market: Dec 15, 2025, 7:10 AM EST
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $4.33 billion as of December 15, 2025. Its market cap has increased by 60.16% in one year.
Market Cap
4.33B
Enterprise Value
4.39B
1-Year Change
60.16%
Ranking
Category
Stock Price
$126.79
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $4.33B, an increase of 857.60%. That is a compound annual growth rate of 40.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 4.33B | 107.07% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | 540.50M | 34.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |